Sign in
Author
|
Conference
|
Journal
|
Organization
|
Year
|
DOI
Look for results that meet for the following criteria:
since
equal to
before
between
and
Search in all fields of study
Limit my searches in the following fields of study
Agriculture Science
Arts & Humanities
Biology
Chemistry
Computer Science
Economics & Business
Engineering
Environmental Sciences
Geosciences
Material Science
Mathematics
Medicine
Physics
Social Science
Multidisciplinary
Authors
(48764)
Rafael Rosell
230
Frances A. Shepherd
154
Ritsuko R. Komaki
148
Cesare Gridelli
147
Masahiro Fukuoka (福岡正博)
134
Conferences
(15)
EMBC
5
ICBBE
4
ICMLA
3
BMEI
3
IEEE International Symposium on Biomedical Imaging
2
Journals
(920)
Lung Cancer
3552
J THORAC ONCOL
1008
INT J RADIAT ONCOL BIOL PHYS
813
EUR J CANCER
584
EJC SUPPL
394
Keywords
(843)
Subscribe
Academic
Keywords
Non Small Cell Lung Cancer
NSCLC,Non Small Cell Lung Cancer,non small cell lung cancers,non small cells lung cancer
Non Small Cell Lung Cancer - NSCLC
Publications: 18,214
|
Citation Count: 175,784
Stemming Variations:
non small cell lung cancers, non small cells lung cancer
Cumulative
Annual
Definition Context
(5)
Non-small cell lung cancer (NSCLC) is a difficult disease to treat. The c-Met receptor is an attractive potential target for novel therapeutic inhibition in human cancers...
Patrick C. Ma
,
et al.
Functional Expression and Mutations of c-Met and Its Therapeutic Inhib...
Non-small cell lung cancer (NSCLC) is an aggressive disease that is generally resistant to chemotherapy...
DAVID J. STEWART
.
Update on the Role of Topotecan in the Treatment of Non-Small Cell Lun...
Non-small cell lung cancer (NSCLC) is the leading cause of cancer deaths for both men and women in our society. Patients with advanced-stage NSCLC managed with supportive care alone have a median survival of 5 months, and only 10% live 1 year. Treatment with chemotherapy can make a difference, and it is therefore of paramount importance to understand the latest data regarding effective treatment regimens for advanced NSCLC. In 1995, the NSCLC Collaborative Group published a meta-analysis of chemotherapy in lung cancer, which included 52 studies involving 9387 patients...
M. Cobo
,
et al.
AVANCES EN EL TRATAMIENTO SISTÉMICO DEL CÁNCER DE PULMÓN NO MICROCÍTIC...
Non-small cell lung cancer (NSCLC) is the most deadly cancer in the world. Vinorelbine is an active vinca-alkaloid with a broad spectrum of anti-tumour activity. In particular, it has high activity in NSCLC, where a synergy with cisplatin has been demonstrated...
Jean Trédaniel
,
et al.
pharmacotherapy Update: Vinorelbine in the Treatment of non-small-cell...
Non-small cell lung cancer (NSCLC) is the leading cause of death from cancer worldwide and has a poor overall survival across all stages of disease. The recent advancement of gene expression technology addresses the phenotypic complexity of many diseases, including NSCLC. These genomic approaches have shown great promise in NSCLC in helping to improve risk stratification, prognosis, and the clinician’s ability to match the right therapy to an individual patient...
Aubrey Jolly Graham
,
et al.
Translating genomics into clinical practice: Applications in lung canc...
Sort by:
Publications
(18214)
EphB3 suppresses non-small-cell lung cancer metastasis via a PP2A/RACK1/Akt signalling complex
Guo Li
,
Xiao-Dan Ji
,
Hong Gao
,
Jiang-Sha Zhao
,
Jun-Feng Xu
,
Zhi-Jian Sun
,
Yue-Zhen Deng
,
Shuo Shi
,
Yu-Xiong Feng
,
Yin-Qiu Zhu
,
Tao Wang
,
Jing-Jing Li
http://academic.research.microsoft.com/io.ashx?type=5&id=56583659&selfId1=28022&selfId2=0&maxNumber=12&query=
Journal:
Nature Communications
, vol. 3, 2012
Methylation Markers of Early-Stage Non-Small Cell Lung Cancer
Kaie Lokk
,
Tõnu Vooder
,
Raivo Kolde
,
Kristjan Välk
,
Urmo Võsa
,
Retlav Roosipuu
,
Lili Milani
,
Krista Fischer
,
Marina Koltsina
,
Egon Urgard
,
Tarmo Annilo
,
Andres Metspalu
http://academic.research.microsoft.com/io.ashx?type=5&id=57405903&selfId1=28022&selfId2=0&maxNumber=12&query=
Journal:
PLOS One
, vol. 7, no. 6, 2012
CDA: Combinatorial Drug Discovery Using Transcriptional Response Modules
Ji-Hyun Lee
,
Dae Gyu Kim
,
Tae Jeong Bae
,
Kyoohyoung Rho
,
Ji-Tae Kim
,
Jong-Jun Lee
,
Yeongjun Jang
,
Byung Cheol Kim
,
Kyoung Mii Park
,
Sunghoon Kim
Journal:
PLOS One
, vol. 7, no. 8, 2012
Pemetrexed plus Platinum as the First-Line Treatment Option for Advanced Non-Small Cell Lung Cancer: A Meta-Analysis of Randomized Controlled Trials
Ming Li
,
Qian Zhang
,
Peifang Fu
,
Ping Li
,
Aimei Peng
,
Guoliang Zhang
,
Xiaolian Song
,
Min Tan
,
Xuan Li
,
Yang Liu
,
Yueping Wu
,
Suyun Fan
http://academic.research.microsoft.com/io.ashx?type=5&id=57404733&selfId1=28022&selfId2=0&maxNumber=12&query=
Journal:
PLOS One
, vol. 7, no. 5, 2012
P6 CAVITATING NON-SMALL CELL LUNG CANCER: DOES IT REPRESENT A MORE AGGRESSIVE DISEASE?
J. Maguire
,
V. Kelly
,
A. Armour
,
C. Smyth
,
M. Ledson
,
M. Walshaw
,
G. Horan
,
T. V. Ajithkumar
,
T. W. Roques
,
W. M. C. Martin
Published in 2012.